Business, Policy & Funding
Breaking news on business, policy, and funding in the life science industry.
Quantum-Si Regains Compliance With Nasdaq Listing Requirements
As of Dec. 4, the firm’s stock had closed above $1 per share for 10 consecutive business days, bringing it back into compliance with the Nasdaq's rules.
BioMérieux Gets Special 510(k) Clearance from FDA for Tropical Fever Panel
The panel detects pathogens that cause chikungunya, dengue, leptospirosis, and malaria using the firm's BioFire system.
DNAnexus, Panomics Partner to Offer Multiomics Data Analysis Platform for Biopharma Researchers
The collaborators hope their integrated product will boost transcriptomics and proteomics data analysis workflows for biomarker discovery and drug repurposing.
Top Five Articles on GenomeWeb Last Week: FDA Guidance for ctDNA, Oxford Nanopore Sues BGI, More
Last week, GenomeWeb’s readers were most interested in the final FDA guidance for using ctDNA as a clinical trial endpoint.
T2 Biosystems to Outlicense Infectious Disease Testing Technology
The firm said its T2 Magnetic Resonance technology for testing whole-blood samples could be paired with fluorescence and other testing methods.